Figure 2.
![Neutrophil and platelet counts on venetoclax and azacitidine maintenance. Peripheral blood counts for patients on DL1 (42-day cycles with 8 planned cycles) and DL2 (28-day cycles with 12 planned cycles) and maintenance Ven/Aza on days 1, 8, 15, and 22 of cycle 1, and then days 1 and 15 each of each subsequent cycle. (A) Median ANC (K/μL) (± standard deviation [SD]) with dashed line at grade 4 neutrophil level (<0.5 x 103/μL). (B) Median platelet counts (K/μL) (± SD) with dashed line representing grade 3 platelet level (<50 x103/μL). The bars in all plots represent median values with error bars representing the interquartile range between the 25% and 75% quartiles. Details for each time point are shown in supplemental Tables 3-4.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/8/4/10.1182_bloodadvances.2023012120/2/blooda_adv-2023-012120-gr2.jpeg?Expires=1719001958&Signature=dabEZKm0jbrDZALPeQTnGuCV9rbYsbB4wpc6seOPEs8TZncG4Yw4KkSnU2CVq68CZYgifhFoSjTr55KoXzmvIdNEBdhJb~Ddswrba4s6G2lPyw8MzcFuRqwRY~9ZfYJXa-dwlqippoGLqonShbjmeqoxiw0kLd4Ouav3z5Dt~xO1W~AdL~stSjxUzAhzIrP5aG~CcrdizhE0ts-9zxFrWiT3DEEwGhqhnvHHCtb3WPsY5fVk6vygTq-UuanGNB0raQHMAQx4RzqODy07neOXc2gpT3U3QKi7EZq6dmPqMvzhWEhZmcTPXcXZ1Kxba2YNGPBWbmTimqtoS4Nm4P989g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Neutrophil and platelet counts on venetoclax and azacitidine maintenance. Peripheral blood counts for patients on DL1 (42-day cycles with 8 planned cycles) and DL2 (28-day cycles with 12 planned cycles) and maintenance Ven/Aza on days 1, 8, 15, and 22 of cycle 1, and then days 1 and 15 each of each subsequent cycle. (A) Median ANC (K/μL) (± standard deviation [SD]) with dashed line at grade 4 neutrophil level (<0.5 x 103/μL). (B) Median platelet counts (K/μL) (± SD) with dashed line representing grade 3 platelet level (<50 x103/μL). The bars in all plots represent median values with error bars representing the interquartile range between the 25% and 75% quartiles. Details for each time point are shown in supplemental Tables 3-4.
